-
Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
Proc Natl Acad Sci U S A. 1974 Oct;71(10):4006-10
PMID: 4372601
-
Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
J Virol. 1990 May;64(5):2126-34
PMID: 2157875
-
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).
Int J Cancer. 1977 Jan;19(1):27-33
PMID: 188769
-
Induction and decay of human fibroblast interferon mRNA.
Proc Natl Acad Sci U S A. 1977 Oct;74(10):4415-9
PMID: 270686
-
Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
J Virol. 1980 Nov;36(2):506-18
PMID: 6253674
-
Transcriptional control signals of a eukaryotic protein-coding gene.
Science. 1982 Jul 23;217(4557):316-24
PMID: 6283634
-
Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
J Virol. 1984 Aug;51(2):411-9
PMID: 6086953
-
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature. 1984 Jul 19-25;310(5974):207-11
PMID: 6087149
-
Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.
Proc Natl Acad Sci U S A. 1984 Nov;81(22):7161-5
PMID: 6438633
-
Human beta-interferon gene expression is regulated by an inducible enhancer element.
Cell. 1985 Jun;41(2):509-20
PMID: 3986910
-
The human beta-interferon gene enhancer is under negative control.
Cell. 1986 May 23;45(4):601-10
PMID: 3708688
-
Detection of factors that interact with the human beta-interferon regulatory region in vivo by DNAase I footprinting.
Cell. 1986 May 23;45(4):611-8
PMID: 3708689
-
Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.
Immunology. 1986 Aug;58(4):591-5
PMID: 2426189
-
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.
Int J Cancer. 1987 Apr 15;39(4):472-6
PMID: 3030940
-
Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer.
Cell. 1987 May 8;49(3):357-67
PMID: 3032451
-
Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6
PMID: 3033649
-
Regulation of inducible and tissue-specific gene expression.
Science. 1987 Jun 5;236(4806):1237-45
PMID: 3296191
-
The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.
EMBO J. 1987 Jun;6(6):1637-42
PMID: 3038527
-
Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells.
J Gen Virol. 1987 Sep;68 ( Pt 9):2407-18
PMID: 2821180
-
Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
J Virol. 1988 Mar;62(3):894-901
PMID: 2828684
-
Overlapping positive and negative regulatory domains of the human beta-interferon gene.
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1447-51
PMID: 3422743
-
Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
Int J Cancer. 1988 Sep 15;42(3):329-38
PMID: 2843473
-
The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
Nucleic Acids Res. 1988 Sep 12;16(17):8391-410
PMID: 2843816
-
Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.
Proc Natl Acad Sci U S A. 1988 Nov;85(21):7952-6
PMID: 2847148
-
Enhancers: mechanisms of action and cell specificity.
Annu Rev Cell Biol. 1988;4:127-53
PMID: 2848550
-
Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
J Virol. 1989 Jun;63(6):2768-72
PMID: 2542588
-
Viral latency and transformation: the strategy of Epstein-Barr virus.
Cell. 1989 Jul 14;58(1):5-8
PMID: 2546674
-
Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
Nature. 1989 Aug 3;340(6232):393-7
PMID: 2547164
-
The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain.
Cell. 1989 Aug 25;58(4):741-53
PMID: 2504497
-
Transcriptional repression of eukaryotic promoters.
Cell. 1989 Nov 3;59(3):405-8
PMID: 2572326
-
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62
PMID: 2556717
-
cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.
J Virol. 1990 Apr;64(4):1855-8
PMID: 2157069
-
Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction.
Exp Cell Res. 1975 May;92(2):478-84
PMID: 165958